Stocks
CLUP IncCLUP
HealthcareBiotechnology
A clinical-stage biopharmaceutical company developing targeted therapies for oncology and rare diseases. Its pipeline focuses on small molecule and antibody-drug conjugate platforms, with lead programs in Phase 2 trials. Investors track CLUP for its potential in high-value niche indications and partnership opportunities.
Congressional Interest in CLUP Inc (CLUP)
1 member of Congress has disclosed 1 trade in CLUP Inc (CLUP), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading CLUP?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-06-17 | MICHAEL T. MCCAUL | buy | $1K-$15K |